Abstract
Multinational companies have invested continuously, a significant sum in search of new technologies to provide the properties of biocompatibility and anti-infective action in polymeric prosthetic medical devices. Although new technologies coupled to polymeric implants have driven a dizzying market (order of $ 200 billion / year in the USA), the current rate of complications after implanta…
